FDA Releases Quarterly List of Drugs Under Review
Quarterly List of Drugs Under Review. U.S. health regulators are currently probing possible safety issues of more than a dozen drugs. The drugs currently under review include the cancer drug Sutent, gandolinium-based contrast agents used in MRIs, and Reclast, which is used treat post-menopausal osteoporosis. The medications were … [Read more...]
Chantix Under Review by FDA After Traffic Accident Report
Chantix Under Review by The FDA. Reports of traffic accidents by users have prompted federal regulators to take another look at the safety information on the Chantix label. Word of the latest Food & Drug Administration (FDA) review comes just days after a non-profit drug research group released a report that found, in the first … [Read more...]